Stock Groups

Pfizer, BioNTech ask U.S. regulators to OK COVID-19 vaccine for kids By Reuters

by Mike Robinson

[ad_1]

© Reuters

WASHINGTON, (Reuters) – Pfizer Inc (NYSE.) and BioNTech announced on Thursday that they have asked U.S. regulators approve the emergency use their COVID-19 vaccination for children aged between 5-11 years. Pfizer stated in a tweet (NYSE.

“We submitted our formal request together with @BioNTech_Group to

@US_FDA Emergency Use Authorization for (EUA) our #COVID19 vaccine to children under 5 years old

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]